Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus type 2 (AAV2) has proven to be a valuable vector for gene therapy. Characterization of the functional domains of the AAV capsid proteins can facilitate our understanding of viral tissue tropism, immunoreactivity, viral entry, and DNA packaging, all of which are important issues for generating improved vectors. To obtain a comprehensive genetic map of the AAV capsid gene, we have constructed 93 mutants at 59 different positions in the AAV capsid gene by site-directed mutagenesis. Several types of mutants were studied, including epitope tag or ligand insertion mutants, alanine scanning mutants, and epitope substitution mutants. Analysis of these mutants revealed eight separate phenotypes. Infectious titers of the mutants revealed four classes. Class 1 mutants were viable, class 2 mutants were partially defective, class 3 mutants were temperature sensitive, and class 4 mutants were noninfectious. Further analysis revealed some of the defects in the class 2, 3, and 4 mutants. Among the class 4 mutants, a subset completely abolished capsid formation. These mutants were located predominantly, but not exclusively, in what are likely to be β-barrel structures in the capsid protein VP3. Two of these mutants were insertions at the N and C termini of VP3, suggesting that both ends of VP3 play a role that is important for capsid assembly or stability. Several class 2 and 3 mutants produced capsids that were unstable during purification of viral particles. One mutant, R432A, made only empty capsids, presumably due to a defect in packaging viral DNA. Additionally, five mutants were defective in heparan binding, a step that is believed to be essential for viral entry. These were distributed into two amino acid clusters in what is likely to be a cell surface loop in the capsid protein VP3. The first cluster spanned amino acids 509 to 522; the second was between amino acids 561 and 591. In addition to the heparan binding clusters, hemagglutinin epitope tag insertions identified several other regions that were on the surface of the capsid. These included insertions at amino acids 1, 34, 138, 266, 447, 591, and 664. Positions 1 and 138 were the N termini of VP1 and VP2, respectively; position 34 was exclusively in VP1; the remaining surface positions were located in putative loop regions of VP3. The remaining mutants, most of them partially defective, were presumably defective in steps of viral entry that were not tested in the preliminary screening, including intracellular trafficking, viral uncoating, or coreceptor binding. Finally, in vitro experiments showed that insertion of the serpin receptor ligand in the N-terminal regions of VP1 or VP2 can change the tropism of AAV. Our results provide information on AAV capsid functional domains and are useful for future design of AAV vectors for targeting of specific tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793 · cited 1×
“Low-passage-number (passages 27 to 38) HFK 293 cells (17) and HeLa cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 U/ml) at 37°C and 5% CO2.”
MethodSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381 · cited 1×
“adenovirus (Ad) helper genes (46); and (iii) pTRUF5, which contains the green”
BackgroundHigh-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis
Cunningham, B. C., & Wells, J. A. (1989) · Science · doi:10.1126/science.2471267 · Cited by 1,367
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Self-citationKaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O'Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 754
Self-citationNucleotide sequence and organization of the adeno-associated virus 2 genome
Srivastava, A., Lusby, E. W., & Berns, K. I. (1983) · Journal of Virology · doi:10.1128/jvi.45.2.555-564.1983 · Cited by 721 · cited 1×
“7 kb that contains two large open reading frames (ORFs), rep and cap (35).”
BackgroundαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 547
The Three-Dimensional Structure of Canine Parvovirus and Its Functional Implications
Tsao, J., Chapman, M. S., Agbandje, M., Keller, W., Smith, K., Wu, H., Luo, M., Smith, T. J., Rossmann, M. G., Compans, R. W., et al. (1991) · Science · doi:10.1126/science.2006420 · Cited by 512
Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490
Self-citationHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deléage, G., & Hallek, M. (1999) · Nature Medicine · doi:10.1038/12491 · Cited by 405
Herpes Simplex Virus Types 1 and 2 Completely Help Adenovirus-Associated Virus Replication
Buller, R. M. L., Janik, J. E., Sebring, E. D., & Rose, J. A. (1981) · Journal of Virology · doi:10.1128/jvi.40.1.241-247.1981 · Cited by 332
Song, S., Morgan, M., Ellis, T., Poirier, A., Chesnut, K., Wang, J., Brantly, M., Muzyczka, N., Byrne, B. J., Atkinson, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14384 · Cited by 304
Self-citationHermonat, P. L., Labow, M. A., Wright, R., Berns, K. I., & Muzyczka, N. (1984) · Journal of Virology · doi:10.1128/jvi.51.2.329-339.1984 · Cited by 299
Self-citationTratschin, J. D., Miller, I. L., & Carter, B. J. (1984) · Journal of Virology · doi:10.1128/jvi.51.3.611-619.1984 · Cited by 270
Klein, R. L., Meyer, E. M., Peel, A. L., Zolotukhin, S., Meyers, C., Muzyczka, N., & King, M. A. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6736 · Cited by 251
Self-citationCloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
Chiorini, J. A., Yang, L., Liu, Y., Safer, B., & Kotin, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6823-6833.1997 · Cited by 231
Rossmann, M. G. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63732-9 · Cited by 226
Santiago, F. S., Lowe, H. C., Kavurma, M. M., Chesterman, C. N., Baker, A., Atkins, D. G., & Khachigian, L. M. (1999) · Nature Medicine · doi:10.1038/71020 · Cited by 219
Subcellular compartmentalization of adeno-associated virus type 2 assembly
Wistuba, A., Kern, A., Weger, S., Grimm, D., & Kleinschmidt, J. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1341-1352.1997 · Cited by 219 · cited 2×
“monoclonal antibody (MAb) B1, directed against the capsid proteins (43).”
BackgroundFunctional implications of the structure of the murine parvovirus, minute virus of mice
Agbandje-McKenna, M., Llamas-Saiz, A. L., Wang, F., Tattersall, P., & Rossmann, M. G. (1998) · Structure · doi:10.1016/s0969-2126(98)00137-3 · Cited by 218 · cited 1×
“The topographic location of the putative heparan binding region is consistent with regions that have been suggested as being involved in host cellular factor(s) recognition and implicated in tissue tropism and in vivo pathogenicity for other parvoviruses (3, 4, 24, 39).”
BackgroundSelf-citationAdeno-Associated Viruses: An Update
Berns, K. I., & Bohenzky, R. A. (1987) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60479-0 · Cited by 207
Structure, Sequence, and Function Correlations among Parvoviruses
Chapman, M. S., & Rossmann, M. G. (1993) · Virology · doi:10.1006/viro.1993.1288 · Cited by 201
Grimm, D., Kern, A., Pawlita, M., Ferrari, F. K., Samulski, R. J., & Kleinschmidt, J. A. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300946 · Cited by 195 · cited 1×
“The A20 antibody recognizes only intact AAV particles (43) and is useful for determining the physical particle titer irrespective of whether the capsids contain DNA (18).”
BackgroundStructure determination of feline panleukopenia virus empty particles
Agbandje, M., McKenna, R., Rossmann, M. G., Strassheim, M. L., & Parrish, C. R. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160204 · Cited by 172
Wistuba, A., Weger, S., Kern, A., & Kleinschmidt, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5311-5319.1995 · Cited by 147 · cited 1×
“The A20 antibody detects both full and empty particles (44).”
BackgroundAdeno-associated virus expression systems for gene transfer
Rabinowitz, J. E., & Samulski, J. R. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80031-1 · Cited by 142
Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus
Rabinowitz, J. E., Xiao, W., & Samulski, R. J. (1999) · Virology · doi:10.1006/viro.1999.0045 · Cited by 136 · cited 21×
“Three structural proteins, designated VP1, VP2, and VP3, are encoded in the cap ORF and made from the p40 promoter by use of alternative splicing and alternative start codons.”
BackgroundInfluentialSelf-citationErratum: Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
Girod, A., Ried, M. U., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deléage, G., & Hallek, M. J. (1999) · Nature Medicine · doi:10.1038/71021 · Cited by 136
Yang, Q., Mamounas, M., Yu, G., Kennedy, S., Leaker, B., Merson, J., Wong-Staal, F., Yu, M., & Barber, J. R. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1929 · Cited by 127
The Structure of Human Parvovirus B19 at 8 Å; Resolution
Agbandje, M., Kajigaya, S., McKENNA, R. V., Young, N. S., & Rossmann, M. G. (1994) · Virology · doi:10.1006/viro.1994.1460 · Cited by 116
Ponnazhagan, S., Mukherjee, P., Wang, X. S., Qing, K., Kube, D. M., Mah, C., Kurpad, C., Yoder, M. C., Srour, E. F., & Srivastava, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8262-8267.1997 · Cited by 112
Ruffing, M., Zentgraf, H., & Kleinschmidt, J. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6922-6930.1992 · Cited by 109 · cited 3×
“(33) showed previously that VP1 and VP2 but not VP3 contained nuclear localization signals (NLS), and three putative NLS are located in the VP1/VP2 region at aa 121 to 125, 141 to 145, and 167 to 171.”
BackgroundZhou, S. Z., Cooper, S. H., Kang, L. Y., Ruggieri, L. M., Heimfeld, S., Srivastava, A., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1867 · Cited by 109
McCarty, D. M., Christensen, M., & Muzyczka, N. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.2936-2945.1991 · Cited by 103
Self-citationFisher-Adams, G., Wong, K. J., Podsakoff, G., Forman, S., & Chatterjee, S. (1996) · Blood · doi:10.1182/blood.v88.2.492.bloodjournal882492 · Cited by 103
McKenna, R., Olson, N. H., Chipman, P. R., Baker, T. S., Booth, T. F., Christensen, J., Aasted, B., Fox, J. M., Bloom, M. E., Wolfinbarger, J. B., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6882-6891.1999 · Cited by 84
Self-citationStudies on the relationship between adeno-associated virus type 1 (AAV-1) and adenoviruses
Casto, B. C., Armstrong, J. A., Atchison, R. W., & Hammon, W. M. (1967) · Virology · doi:10.1016/0042-6822(67)90120-1 · Cited by 75
Adenovirus and Adeno‐Associated Virus as Vectors for Gene Therapya
Berns, K. I., & Giraud, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44735.x · Cited by 72
Hoque, M., Ishizu, K.-I., Matsumoto, A., Han, S.-I., Arisaka, F., Takayama, M., Suzuki, K., Kato, K., Kanda, T., Watanabe, H., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7912-7915.1999 · Cited by 70
Barbis, D. P., Chang, S., & Parrish, C. R. (1992) · Virology · doi:10.1016/0042-6822(92)90192-r · Cited by 66
In Vitro Packaging of Adeno-Associated Virus DNA
Zhou, X., & Muzyczka, N. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3241-3247.1998 · Cited by 63
Self-citationWeger, S., Wendland, M., Kleinschmidt, J. A., & Heilbronn, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.260-269.1999 · Cited by 56
Muralidhar, S., Becerra, S. P., & Rose, J. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.170-176.1994 · Cited by 52 · cited 1×
“assembly studies (33) and capsid initiation codon mutagenesis studies (25) suggested that both VP2 and VP3 were required for capsid formation and production of infectious particles, and either VP1 or VP2 was required for nuclear localization of VP3.”
BackgroundTresnan, D. B., Southard, L., Weichert, W. S., Sgro, J.-Y., & Parrish, C. R. (1995) · Virology · doi:10.1006/viro.1995.1385 · Cited by 51
Ruffing, M., Heid, H., & Kleinschmidt, J. A. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-12-3385 · Cited by 37
Gnatenko, D. V., Arnold, T. E., Zolotukhin, S., Nuovo, G. J., Muzyczka, N., & Bahou, W. F. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500211 · Cited by 27
Self-citationGene transfer into hepatoma cell lines via the serpin enzyme complex receptor
Ziady, A. G., Perales, J. C., Ferkol, T. W., Gerken, T. A., Beegen, H., Perlmutter, D. H., & Davis, P. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.2.g545 · Cited by 22
Self-citationShaping animal body plans in development and evolution by modulation of Hox expression patterns
(1998) · doi:10.1002/(sici)1521-1878(199802)20:2
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
“The AAV capsid has been successfully genetically engineered but, in general, AAV engineering has been more 'hit-and-miss', as the AAV capsid does not easily accommodate heterologous peptides and modified vector particles are often unstable or defective at a step subsequent to internalizatio”
BackgroundRabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Self-citationBurger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741
Self-citationGrimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696
“Noteworthy here are approaches to fuse targeting ligands to the N termini of AAV capsid proteins (ideally, VP2 [45, 83]), or more powerful, to insert short peptides (up to 14 amino acids [21], typically 7) into exposed regions of the assembled virion.”
BackgroundThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612
Metadata
- Authors
- Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., & Muzyczka, N.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-09-15
- Volume
- 74
- Issue
- 18
- Pages
- 8635-8647
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2009681413
- Cited by
- 390
- References
- 54
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.